Total Payments
$2,266
2024 Payments
$647.82
Companies
19
Transactions
34
Medicare Patients
92
Medicare Billing
$6,229
Payment Breakdown by Category
Food & Beverage$2,266 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,266 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $554.32 | 5 | $0 (2023) |
| GENZYME CORPORATION | $259.58 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $247.03 | 2 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $149.49 | 2 | $0 (2024) |
| Amgen Inc. | $134.76 | 2 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $121.84 | 1 | $0 (2022) |
| Vifor Pharma, Inc. | $120.92 | 3 | $0 (2023) |
| NXSTAGE MEDICAL, INC. | $117.12 | 3 | $0 (2024) |
| Ardelyx, Inc. | $106.72 | 2 | $0 (2024) |
| Baxter Healthcare | $84.64 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $647.82 | 9 | GENZYME CORPORATION ($259.58) |
| 2023 | $810.06 | 17 | AstraZeneca Pharmaceuticals LP ($210.43) |
| 2022 | $557.88 | 6 | Horizon Therapeutics plc ($122.35) |
| 2021 | $249.99 | 2 | AstraZeneca Pharmaceuticals LP ($249.99) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $73.01 | General |
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEPHROLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $134.58 | General |
| 10/15/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Nephrology | ||||||
| 09/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardio-renal | ||||||
| 07/18/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology | ||||||
| 04/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/22/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $82.49 | General |
| Category: NEPHROLOGY | ||||||
| 02/19/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Renal | ||||||
| 12/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: KRYSTEXXA | ||||||
| 12/06/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/29/2023 | NxStage Medical, Inc. | NXSTAGE CARTRIDGE EXPRESS (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $42.96 | General |
| Category: Nephrology | ||||||
| 10/13/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Neuromodulation | ||||||
| 09/27/2023 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $62.29 | General |
| Category: Renal | ||||||
| 09/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Cardio-renal | ||||||
| 07/20/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $48.68 | General |
| Category: NEPHROLOGY | ||||||
| 07/11/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $38.26 | General |
| Category: CRITICAL CARE | ||||||
| 07/10/2023 | Abbott Laboratories | PRODIGY (Device) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Neuromodulation | ||||||
| 05/18/2023 | Fresenius USA Marketing, Inc. | CRIT-LINE (Device) | Food and Beverage | In-kind items and services | $53.08 | General |
| Category: System, Hemodialysis, Access Recirculation Monitoring | ||||||
| 05/17/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Hyperkalemia | ||||||
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Nephrology | ||||||
| 03/23/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Hyperkalemia | ||||||
| 03/16/2023 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 02/08/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $37.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 39 | $8,402 | $2,123 |
| 2022 | 1 | 13 | 14 | $5,598 | $1,978 |
| 2021 | 1 | 12 | 12 | $288.00 | $81.48 |
| 2020 | 2 | 28 | 28 | $5,712 | $2,046 |
Total Patients
92
Total Services
93
Medicare Billing
$6,229
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 17 | 17 | $4,594 | $1,127 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 22 | $3,808 | $995.72 | 26.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 13 | 14 | $5,598 | $1,978 | 35.3% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 12 | 12 | $288.00 | $81.48 | 28.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 15 | 15 | $5,400 | $1,971 | 36.5% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2020 | 13 | 13 | $312.00 | $75.24 | 24.1% |
About Bindu Simon, APRN
Bindu Simon, APRN is a Primary Care healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1396266136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bindu Simon, APRN has received a total of $2,266 in payments from pharmaceutical and medical device companies, with $647.82 received in 2024. These payments were reported across 34 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,266).
As a Medicare-enrolled provider, Simon has provided services to 92 Medicare beneficiaries, totaling 93 services with total Medicare billing of $6,229. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Gerontology
- Location Houston, TX
- Active Since 07/02/2017
- Last Updated 03/23/2023
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396266136
Products in Payments
- KRYSTEXXA (Biological) $278.42
- Kerendia (Drug) $149.49
- CABLIVI (Biological) $125.00
- LUPKYNIS (Drug) $121.84
- LOKELMA (Drug) $107.99
- Parsabiv (Drug) $103.37
- FARXIGA (Drug) $102.44
- XPHOZAH 30 MG (Drug) $82.49
- Renal - PD (Device) $62.29
- CRIT-LINE (Device) $53.08
- Veltassa (Drug) $50.44
- RAYALDEE (Drug) $48.68
- NOVALUNG SYSTEM (Device) $45.94
- NXSTAGE CARTRIDGE EXPRESS (Device) $42.96
- TERLIVAZ (Drug) $38.26
- JYNARQUE (Drug) $28.96
- NXSTAGE SYSTEM ONE (Device) $28.22
- VORAXAZE (Drug) $25.24
- ETERNA (Device) $24.57
- IBSRELA (Drug) $24.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Houston
Mrs. Mary Gibbens, Msn, Aprn, A-Gnp-C, MSN, APRN, A-GNP-C
Primary Care — Payments: $16,984
Primary Care $16,984
Ms. Meisha Smith, Fnp-C, FNP-C
Primary Care — Payments: $4,646
Primary Care $4,646
Nonye Nelson, Np, NP
Primary Care — Payments: $4,468
Primary Care $4,468
Hania Tofik
Primary Care — Payments: $3,937
Primary Care $3,937
Joanna Larson, Fnp, FNP
Primary Care — Payments: $3,277
Primary Care $3,277
Mrs. Natalie Greer, Aprn, APRN
Primary Care — Payments: $2,400
Primary Care $2,400